Head of Biomarker Discovery
- Sijainti Turku
Julkaistu 19.01.2026, 13:35 - Haku päättyy 05.02.2026, 23:59
Head of Biomarker Discovery
This is a new role to study our phage-biosensors and their interactions with disease biomarkers. You will be specialized on non-invasive sample matrices, their fundamental characteristics but also their complementing role to serum and to existing diagnostic tests. A key element of your work is to conduct complementary measurements utilizing a Mass Spectrometer and other established methods and to participate in deep analyses with our clinical and research partners. Your duties will also involve documentation, writing scientific publications, and the further development of our biosensor method.
This new role is pivotal in our aim to discover novel biomarkers for a wide range of diseases. We have ongoing studies in Finland, China and in the US. Identification and characterization of new complementary biomarkers paves the way for the development of novel diagnostic tests, enabling accurate early stage screening of a variety of diseases.
We expect you to have
– A M.Sc or PhD in life sciences and/or chemistry.
– Hands-on analysis experience in using LC-MS and other established biophysical methods.
– Experience and understanding of biomarkers in the medical field.
– Understanding of predictive, prognostic and pharmacodynamic biomarkers.
– A proactive attitude and problem solving capabilities are essential to succeed in this role.
– Sufficient communication skills and Fluency in English.
It would be a distinct advantage if you had
– Hands-on research experience in biomarkers e.g. peptides and proteins.
– Understanding in treatment response monitoring and drug-receptor interactions.
– Interdisciplinary thinking and curiosity to further develop existing methods.
– Experience from chemical database/software and molecular modeling.
As a person you are a reliable colleague with a curious mind to learn and share new things. We expect a hard working and collaborative attitude with capability to work as a part of the team. This role is permanent and full-time at our laboratory and office in Turku.
AQ BIOTECH OY
About AQ Biotech
AQ Biotech is a Finnish biotech startup revolutionizing early detection of severe diseases through the engineered, proprietary phage-biosensors. Our innovative, patented method enables accurate screening of various cancers, infectious- and neurological diseases using non-invasive samples like urine and saliva. By leveraging the natural specificity and stability of phages, we provide diagnostic solutions that are significantly more efficient, cost-effective and accessible than traditional methods.
We collaborate with world-class research institutions to accelerate new biomarker discovery, aiming to transform healthcare by providing faster, simpler, and widely available life-saving diagnostics. Based in Turku, Finland, we conduct clinical studies and research projects in Finland, China, and the USA.